Beatrice Nassanga - Concepedia

Author

Beatrice Nassanga

Uganda Virus Research Institute ORCID

Also Known As

Beatrice Nassanga, Beatrice R. Nassanga

Publications

504

Citations

H-Index

Concepts

All Affiliations

Uganda Virus Research Institute London School of Hygiene & Tropical Medicine University of Oxford Jenner Institute Makerere University

About

Beatrice Nassanga is an author at Uganda Virus Research Institute specializing in medicine, epidemiology, and allergy medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	3	378
2	Epidemiology	2	3	378
3	Public Health	1	1	64
4	Allergy	1	1	64
5	Allergy Medicine	1	1	64

Beatrice Nassanga

Publications

332

Citations

H-Index

Page 1

	Year	Citations
BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial Sarah Prentice, Beatrice Nassanga, Emily L. Webb, The Lancet Infectious Diseases NeonatologyPathogenesisUgandan NeonatesPediatricsHeterologous Infectious Disease	2021	157
Understanding asthma phenotypes: the World Asthma Phenotypes (WASP) international collaboration Lucy Pembrey, Maurício L. Barreto, Jeroen Douwes, ERJ Open Research AsthmaInflammatory Lung DiseaseLung InflammationAllergy MedicineGenetic Epidemiology	2018	64
The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial Anne Wajja, Dennison Kizito, Beatrice Nassanga, PLoS neglected tropical diseases	2017	31
Effect of Schistosoma mansoni infection and its treatment on antibody responses to measles catch-up immunisation in pre-school children: A randomised trial Robert Tweyongyere, Beatrice Nassanga, Allan Muhwezi, PLoS neglected tropical diseases	2019	31
A genome‐wide association and replication study of blood pressure in Ugandan early adolescents Swaib A. Lule, Alexander J. Mentzer, Benigna Namara, Molecular Genetics & Genomic Medicine	2019	22
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial Anne Wajja, Beatrice Nassanga, Agnes Natukunda, The Lancet Infectious Diseases	2023	17
Schistosome and malaria exposure and urban–rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials Agnes Natukunda, Gyaviira Nkurunungi, Ludoviko Zirimenya, The Lancet Global Health	2024	10

Page 1